Results 1 to 10 of about 20 (20)
Some of the next articles are maybe not open access.

HLA-B*5701 Screening for Hypersensitivity to Abacavir

New England Journal of Medicine, 2008
Simon Mallal   +2 more
exaly  

Association of the Genetic Marker for Abacavir Hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos

Pharmacogenomics, 2011
Irma Silva-Zolezzi   +2 more
exaly  

HLA-B*5701 frequency n Chilean HIV-infected patients and in general population

Brazilian Journal of Infectious Diseases, 2010
Sandra Solari
exaly  

HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing

Tissue Antigens, 2005
D Nolan, S Mallal
exaly  

HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay

Tissue Antigens, 2007
D Nolan, S Mallal
exaly  

Peptide binding specificities of HLA-B*5701 and B*5801

Science China Life Sciences, 2012
Hu Mei, Xianchao Pan, Wen Tan
exaly  

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

Lancet, The, 2002
S Mallal, D Nolan, D Maxwell
exaly  

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure

Pharmacotherapy, 2019
Chris M Stainsby   +2 more
exaly  

Successful implementation of a national HLA‐B*5701 genetic testing service in Canada

Tissue Antigens, 2010
Anita Rachlis   +2 more
exaly  

Abacavir-induced reaction with fever and severe skin rash in a patient tested human leukocyte antigen-B*5701 negative

International Journal of STD and AIDS, 2009
V Colangeli
exaly  
1  2  

Home - About - Disclaimer - Privacy